T. Rowe Price Investment Management Inc. Boosts Stock Position in Mettler-Toledo International, Inc. $MTD

by · The Cerbat Gem

T. Rowe Price Investment Management Inc. raised its holdings in Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 0.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 691,565 shares of the medical instruments supplier’s stock after purchasing an additional 3,157 shares during the quarter. T. Rowe Price Investment Management Inc. owned 3.40% of Mettler-Toledo International worth $964,174,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. EverSource Wealth Advisors LLC grew its position in Mettler-Toledo International by 2.4% during the third quarter. EverSource Wealth Advisors LLC now owns 294 shares of the medical instruments supplier’s stock valued at $361,000 after buying an additional 7 shares during the period. Allworth Financial LP boosted its stake in Mettler-Toledo International by 6.1% in the third quarter. Allworth Financial LP now owns 121 shares of the medical instruments supplier’s stock valued at $149,000 after acquiring an additional 7 shares during the last quarter. Evergreen Capital Management LLC boosted its stake in Mettler-Toledo International by 4.5% in the fourth quarter. Evergreen Capital Management LLC now owns 184 shares of the medical instruments supplier’s stock valued at $257,000 after acquiring an additional 8 shares during the last quarter. Meridian Wealth Management LLC grew its position in shares of Mettler-Toledo International by 1.7% during the 4th quarter. Meridian Wealth Management LLC now owns 488 shares of the medical instruments supplier’s stock valued at $680,000 after acquiring an additional 8 shares during the period. Finally, Verdence Capital Advisors LLC increased its stake in shares of Mettler-Toledo International by 2.0% during the 4th quarter. Verdence Capital Advisors LLC now owns 458 shares of the medical instruments supplier’s stock worth $639,000 after purchasing an additional 9 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently commented on MTD. Barclays lowered their price target on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Robert W. Baird dropped their price target on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research report on Monday, May 11th. JPMorgan Chase & Co. reduced their target price on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a research note on Monday, May 11th. Jefferies Financial Group raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and boosted their price target for the company from $1,400.00 to $1,450.00 in a research report on Friday, March 20th. Finally, Citigroup dropped their price target on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research note on Friday, May 8th. Six equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $1,408.55.

Get Our Latest Stock Report on MTD

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,145.08 on Friday. Mettler-Toledo International, Inc. has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,525.17. The stock has a market cap of $23.14 billion, a P/E ratio of 26.85, a PEG ratio of 2.36 and a beta of 1.27. The firm’s fifty day moving average price is $1,194.36 and its 200-day moving average price is $1,302.95.

Mettler-Toledo International (NYSE:MTD – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $8.70 by $0.21. The company had revenue of $947.13 million during the quarter, compared to analyst estimates of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The firm’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the company earned $8.19 earnings per share. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. Sell-side analysts predict that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current year.

Mettler-Toledo International Profile

(Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

Recommended Stories